Canarypox virus

"Canarypox virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A species of AVIPOXVIRUS, subfamily CHORDOPOXVIRINAE. Canarypox virus vectors are used in vaccine and immunotherapy research.

Descriptor ID

D028121

MeSH Number(s)

B04.280.650.160.100.149

B04.909.204.783.160.100.149

Concept/Terms

Canarypox virus

Below are MeSH descriptors whose meaning is more general than "Canarypox virus".

Organisms [B]
Viruses [B04]
DNA Viruses [B04.280]
Poxviridae [B04.280.650]
Chordopoxvirinae [B04.280.650.160]
Avipoxvirus [B04.280.650.160.100]
Canarypox virus [B04.280.650.160.100.149]
Vertebrate Viruses [B04.909]
DNA Viruses [B04.909.204]
Poxviridae [B04.909.204.783]
Chordopoxvirinae [B04.909.204.783.160]
Avipoxvirus [B04.909.204.783.160.100]
Canarypox virus [B04.909.204.783.160.100.149]

Below are MeSH descriptors whose meaning is related to "Canarypox virus".

Below are MeSH descriptors whose meaning is more specific than "Canarypox virus".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Canarypox virus" by people in Harvard Catalyst Profiles by year, and whether "Canarypox virus" was a major or minor topic of these publication.

Bar chart showing 8 publications over 7 distinct years, with a maximum of 2 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	0	1	1
2007	0	1	1
2009	1	0	1
2011	0	1	1
2013	1	1	2
2021	0	1	1

Below are the most recent publications written about "Canarypox virus" by people in Profiles.

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults. N Engl J Med. 2021 03 25; 384(12):1089-1100.

View in: PubMed
The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys. J Virol. 2014 Feb; 88(3):1809-14.

View in: PubMed
Nonreplicating vectors in HIV vaccines. Curr Opin HIV AIDS. 2013 Sep; 8(5):412-20.

View in: PubMed
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine. AIDS. 2011 Jan 02; 25(1):27-36.

View in: PubMed
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 2009 Oct 09; 27(43):6088-94.

View in: PubMed
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. J Acquir Immune Defic Syndr. 2007 Feb 01; 44(2):203-12.

View in: PubMed
Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study. J Infect Dis. 2003 Mar 15; 187(6):887-95.

View in: PubMed
Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys. J Immunol. 2002 Feb 15; 168(4):1847-53.

View in: PubMed
Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. Curr Opin Mol Ther. 1999 Aug; 1(4):471-9.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Vaccine
J Virol
J Immunol
N Engl J Med
J Infect Dis
J Acquir Immune Defic Syndr
Curr Opin Mol Ther
Curr Opin HIV AIDS
AIDS